BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 377718)

  • 1. Mode of action of cyclosporin A: a new immunosuppressive agent.
    White DJ; Calne RY; Plumb A
    Transplant Proc; 1979 Mar; 11(1):855-9. PubMed ID: 377718
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival of cardiac allografts in rats treated with cyclosporin A.
    Jamieson SW; Burton NA; Bieber CP; Reitz BA; Oyer PE; Stinson EB; Shumway NE
    Surg Forum; 1979; 30():289-91. PubMed ID: 395684
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells.
    White DJ; Plumb AM; Pawelec G; Brons G
    Transplantation; 1979 Jan; 27(1):55-8. PubMed ID: 155909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
    Lin Y; Goebels J; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporin-A-induced long-term survival of fully incompatible skin and heart grafts in rats.
    White DJ; Rolles K; Ottawa T; Turell O
    Transplant Proc; 1980 Jun; 12(2):261-5. PubMed ID: 6994294
    [No Abstract]   [Full Text] [Related]  

  • 6. Properties of cyclosporin--A-induced graft acceptance.
    White DJ; Timmerman W; Davies HS; Nagao T; Kasahara K; Plumb A
    Transplant Proc; 1981 Mar; 13(1 Pt 1):379-82. PubMed ID: 7022857
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of canine pancreas allografts with cyclosporin A.
    McMaster P; Procyshyn A; Calne RY; Valdes R; Rolles K; Smith D
    Transplant Proc; 1980 Jun; 12(2):275-7. PubMed ID: 6771904
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of cardiac allograft prolongation by cyclosporin-A.
    Hutchinson IF; Shadur CA; Duarte A; Baldwin WM; Strom TB; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):412-3. PubMed ID: 6455797
    [No Abstract]   [Full Text] [Related]  

  • 9. FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC) II. Biological activities in animal models.
    Mori H; Abe F; Furukawa S; Furukawa S; Sakai F; Hino M; Fujii T
    J Antibiot (Tokyo); 2003 Feb; 56(2):80-6. PubMed ID: 12715865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of immunosuppressive agents on T and B lymphocytes.
    Thomas F; Owens L; Thomas J; Wolf JS; Volk M; Mendez G; Lee HM
    Proc Clin Dial Transplant Forum; 1974; (4):124-9. PubMed ID: 4619655
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
    Pearson TC; Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of cyclosporin A on experimental pancreas allografts in the rat.
    Garvey JF; McShane P; Poole MD; Millard PR; Morris PJ
    Transplant Proc; 1980 Jun; 12(2):266-9. PubMed ID: 6771902
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic manipulation: specific mechanisms.
    Brent L
    Transplant Proc; 1979 Mar; 11(1):839-44. PubMed ID: 313106
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin A prolongation of segmental pancreatic and islet allograft function in rats.
    Rynasiewicz JJ; Sutherland DE; Kawahara K; Gorecki P; Najarian JS
    Transplant Proc; 1980 Jun; 12(2):270-4. PubMed ID: 6771903
    [No Abstract]   [Full Text] [Related]  

  • 15. Orthotopic heart and combined heart and lung transplantation with cyclosporin-A immune suppression.
    Reitz BA; Bieber CP; Raney AA; Pennock JL; Jamieson SW; Oyer PE; Stinson EB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):393-6. PubMed ID: 6791329
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.
    Larsson EL
    J Immunol; 1980 Jun; 124(6):2828-33. PubMed ID: 6966298
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological characteristics of a novel immunosuppressant, IR-1116, specific for B lymphocytes.
    Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):734-7. PubMed ID: 8382385
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological immunosuppression in clinical organ grafting. Observations on four agents: cyclosporin A, Asta 5122 (cytimun), lambda carrageenan and promethazine hydrochloride.
    Calne RY
    Clin Exp Immunol; 1979 Jan; 35(1):1-9. PubMed ID: 371877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.
    Walliser P; Benzie CR; Kay JE
    Immunology; 1989 Nov; 68(3):434-5. PubMed ID: 2480331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclosporin A on the generation of primed lymphocytes in vitro.
    Leapman SB; Filo RS; Smith EJ; Smith PG
    Transplant Proc; 1980 Jun; 12(2):246-51. PubMed ID: 7394879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.